Phenotypic Determinants and Clinical Implications of Creatinine-Cystatin C eGFR Discordance in Nigerian Adults

The Kidney's Two Messengers

Imagine your kidneys as a busy, high-tech factory that filters your blood, removing waste and keeping your body in perfect balance. To make sure this factory is running smoothly, doctors need a way to check its output. They don't usually open the machine up to look inside; instead, they listen to the "messengers" the factory sends out into your bloodstream. Two of the most important messengers are creatinine and cystatin C.

Creatinine is like a messenger who is heavily influenced by how much you eat and how much muscle you have. If you are a bodybuilder who eats a lot of meat, this messenger might run a bit faster or slower just because of your diet, not because the factory is broken. Cystatin C is a different kind of messenger; it's less bothered by your muscles or your lunch and is generally considered a more direct report on how well the kidneys are actually working.

For a long time, doctors have relied mostly on creatinine to decide if someone has kidney disease. But recently, scientists have noticed something strange: sometimes these two messengers tell completely different stories about the same person. One might say, "Everything is fine!" while the other whispers, "We have a problem!" This paper explores why these two messengers disagree, especially in adults in Nigeria, and what happens when doctors have to choose which story to believe.

---

The Great Kidney Story Swap

In this study, researchers gathered 303 adults in Abuja, Nigeria, to see what happens when they ask both creatinine and cystatin C to report on kidney health. They split the group into two teams: the "Healthy Team" (people with no known kidney issues) and the "CKD Team" (people already diagnosed with Chronic Kidney Disease).

The researchers used a special mathematical recipe called the CKD-EPI 2021 equation to turn the levels of these messengers into a score called the eGFR (estimated Glomerular Filtration Rate). Think of this score as a "health grade" for the kidney factory. A high grade means the factory is working great; a low grade means it's struggling.

The Tale of Two Teams

The most surprising discovery was that the two messengers didn't agree on the story for everyone. In fact, their agreement depended entirely on whether the person was healthy or already sick.

• For the Healthy Team: The two messengers were like strangers who barely knew each other. They disagreed wildly. In this group, the creatinine score and the cystatin C score were often very different from each other. The study found that 81.8% of healthy people had a difference of at least 15 mL/min per 1.73 m² between the two scores. That's a huge gap! It's like one messenger saying, "I'm running a marathon," and the other saying, "I'm walking to the mailbox."
• For the CKD Team: Once kidney disease was established, the messengers suddenly started telling the same story. They agreed much better, with a high level of consistency.

Why Do They Disagree?

The researchers dug deeper to find out why the messengers were fighting. They discovered that the "boss" controlling the messengers changed depending on who you were.

• In Healthy People: The biggest boss was Sex. Being male or female was the main reason the scores differed. Men tended to have higher creatinine levels (because they usually have more muscle), which made their kidney scores look lower than they actually were, while women's scores looked higher.
• In People with Kidney Disease: The boss changed! Sex stopped mattering. Instead, Mean Arterial Pressure (MAP)—a measure of blood pressure—became the main driver. In sick kidneys, the blood pressure seemed to be the thing that made both messengers run faster or slower together.

The Great Reclassification

Here is where it gets really interesting. Because the two messengers told such different stories, switching from the creatinine story to the cystatin C story changed the "health grade" for half the people in the study.

• 50.5% of all participants (153 people) were moved to a different stage of kidney disease just by changing the test.
• The Healthy Team: When doctors used the cystatin C test, 38.0% of the healthy people were suddenly moved to a higher (more severe) disease stage. It was as if the creatinine test had been too optimistic, and cystatin C was the one pointing out hidden trouble.
• The CKD Team: For the people who already had kidney disease, the cystatin C test often moved them to a lower (less severe) stage. About 59.0% of these patients were reclassified as having milder disease than the creatinine test suggested.

What Does This Mean?

The paper suggests that this disagreement isn't just a mistake in the lab; it's a real biological phenomenon. In healthy people, the difference is mostly about body composition (muscle vs. no muscle). In sick people, the difference is driven by how hard the heart is pumping blood (blood pressure).

The authors conclude that doctors shouldn't just pick one test and stick with it forever. Instead, they suggest a "selective" approach. If a patient has high blood pressure or if the creatinine test seems suspicious (like in a very muscular person or someone with a different body type), adding the cystatin C test could help get the right diagnosis. This is especially important in places like Nigeria and sub-Saharan Africa, where kidney disease is common and resources are limited. Getting the right "health grade" early could mean the difference between catching a problem in time or missing it entirely.

The study doesn't claim to have solved everything—it admits it only looked at one moment in time and didn't measure the actual muscle mass or inflammation in the patients. But it strongly suggests that the way we look at kidney health needs to be smarter, taking into account who the patient is and what stage of disease they are in.